Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ocuphire Pharma Inc (NQ: OCUP )

1.170 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.170
Bid (Size) 1.160 (1)
Ask (Size) 1.200 (32)
Prev. Close 1.170
Today's Range 1.170 - 1.170
52wk Range 1.150 - 3.399
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal
Ocuphire Pharma acquires Opus Genetics, expanding its IRD gene therapy pipeline. The renamed company, Opus Genetics, will trade under "IRD" by late October 2024. 
Via Benzinga
Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders
From Ademi LLP
Via Business Wire

Performance

YTD
-61.89%
-61.89%
1 Month
-9.30%
-9.30%
3 Month
-29.94%
-29.94%
6 Month
-41.79%
-41.79%
1 Year
-57.30%
-57.30%

More News

Read More
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
Via Talk Markets
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Recap: Ocuphire Pharma Q3 Earnings
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
Via InvestorPlace
3 Value Stocks to Buy on the Dip: February 2024
Via InvestorPlace
Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Surprise! These 3 Penny Stocks Pack Powerful Financials.
Via InvestorPlace
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The 7 Best Stocks Under $10 to Buy in May
Via InvestorPlace
7 Small-Cap Biotech Stocks with Massive Potential
Via InvestorPlace
Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.